- Home
- BNRG vs KTTA Comparison
BNRG vs KTTA Comparison
Compare BNRG & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNRG | KTTA |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 5.3M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BNRG | KTTA |
|---|---|---|
| Price | $0.76 | $1.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 67.6K | ★ 21.6M |
| Earning Date | 09-30-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $387,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 843.90 | N/A |
| 52 Week Low | $0.80 | $0.28 |
| 52 Week High | $15.30 | $3.85 |
Technical Indicators
Market Signals| Indicator | BNRG | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 24.48 | 60.34 |
| Support Level | $1.08 | $1.09 |
| Resistance Level | $1.16 | $1.23 |
| Average True Range (ATR) | 0.09 | 0.24 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 2.84 | 47.40 |
Price Performance
Historical ComparisonAbout BNRG Brenmiller Energy Ltd
Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).